Elevated procalcitonin levels in active Wegener's granulomatosis

Journal of Rheumatology

Volumn 25, Issue 8, 1998, Pages 1531-1533

  Moosig, Frank ^a,b   Csernok, Elena ^a,b,c   Reinhold Keller, Eva ^a,b   Schmitt, Willhelm ^a,b   Gross, Wolfgang Ludwig ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Department of Rheumatology ^*

^c Rheumaklinik Bad Bramstedt   (Germany)

Author keywords

Procalcitonin; Wegener's granulomatosis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 2 RECEPTOR; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROCALCITONIN;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; INFECTION; PRIORITY JOURNAL; SEROLOGY; WEGENER GRANULOMATOSIS;

BACTERIAL INFECTIONS; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROTEIN PRECURSORS; WEGENER GRANULOMATOSIS;

EID: 0031928310     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Gross WL. New developments in the treatment of systemic vasculitis. Curr Opin Rheumatol 1994;6:11-9.
2. Le Moullec JM, Jullienne A, Chenais J, et al. The complete sequence of human preprocalcitonin. FEBS Lett 1984;167:93-7.
3. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon F. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8.
4. Zintl F, Sauer M, Fuchs D, Hermann J, Reinhart K. High serum procalcitonin concentrations in children and adults after hemopoietic stem cell transplantation - an indicator for poor prognosis in severe infections [abstract]. Blood 1996;88 Suppl 1:266b.
5. Gendrel D, Assicot M, Raymond J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 1996;128:570-3.
6. Meisner M, Tschaikowsky K, Spiessl C, Schütte J. Procalcitonin - a marker or modulator of the acute immune response? [abstract]. Intensive Care Med 1996;22 Suppl 1:14.
7. Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Kocj KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997;40:1250-6.
8. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
9. Jennette CJ, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
10. Reinhold-Keller E, Kekow J, Schnabel A, et al. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994;37:919-24.